These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 6129141

  • 1. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG, Boehringer K, Weidmann P, Link L, Schiffl H, Ziegler WH.
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [Abstract] [Full Text] [Related]

  • 2. Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.
    Lüscher T, Havelka J, Greminger P, Tuma J, Täuber M, Siegenthaler W, Vetter W.
    Eur J Clin Pharmacol; 1982 Oct; 23(5):411-5. PubMed ID: 6129980
    [Abstract] [Full Text] [Related]

  • 3. Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.
    Larsson R, Karlberg BE, Norlander B, Wirsén A.
    Clin Pharmacol Ther; 1981 May; 29(5):588-93. PubMed ID: 6111409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
    Karlberg BE, Larsson R, Ohman KP, Norlander B, Wirsen A, Hed J, Lundh BL, Flock A.
    Eur J Clin Pharmacol; 1983 May; 25(2):179-86. PubMed ID: 6138257
    [Abstract] [Full Text] [Related]

  • 6. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R, Abdel-Haq B, Magagna A, Leto di Priolo S, Simonini N, Salvetti A.
    Int J Clin Pharmacol Res; 1984 May; 4(2):155-63. PubMed ID: 6147320
    [Abstract] [Full Text] [Related]

  • 7. Prizidilol (SKF 92657) in primary hypertension.
    Karlberg BE, Larsson R, Ohman KP.
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():461s-464s. PubMed ID: 7188585
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K, Weidmann P, Link L, Bianchetti MG, Schiffl H, Reubi FC.
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW, Curry PV, Trounce JR.
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular response to exercise and regional haemodynamics during treatment with prizidilol hydrochloride (SK & F 92 657) in moderately severe essential hypertension.
    Andersson O, Ljungman S, Berglund G.
    Eur J Clin Pharmacol; 1983 May; 25(5):577-80. PubMed ID: 6662157
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.